Technology | 2022.09.06
Coave Therapeutics Strengthens Leadership Team with the Appointments of Catherine Mathis as Vice President Regulatory Affairs and Julien Berger as Head of Legal Affairs
PARIS, Sept. 6, 2022 /PRNewswire/ -- Coave Therapeutics (\'Coave\'), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central Nervous System) and eye diseases, today announced the appointments of Catherine Mathis, PharmD, as Vice President...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]f-legal-affairs-301617871.html
